Focus Partners Wealth
FHTX icon

Focus Partners Wealth’s Foghorn Therapeutics FHTX Stock Holding History

Focus Partners Wealth’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,549
Closed -$240K – 2717
2025
Q3 		$240K Buy
+1,549
New +$8.21K ﹤0.01% 1958
2024
Q3 		– Sell
-215,690
Closed -$1.29M – 1621
2024
Q2 		$1.29M Buy
215,690
+107,920
+100% +$643K ﹤0.01% 744
2024
Q1 		$632K Buy
+107,770
New +$598K 0.01% 678

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Focus Partners Wealth's FHTX Position: Q4 2025 in Review

Focus Partners Wealth sold out of Foghorn Therapeutics (FHTX) in Q4 2025, closing a stake of 1,549 shares — an estimated $240K sold.

Focus Partners Wealth first reported a position in FHTX in Q1 2024 and held it in 3 quarters. The position peaked at $1.29M in Q2 2024. 93 funds tracked by Wall St. Rank hold FHTX as of Q4 2025.

  • Focus Partners Wealth reported no remaining Foghorn Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Focus Partners Wealth sold 1,549 Foghorn Therapeutics shares in Q4 2025, an estimated $240K.
  • Focus Partners Wealth first reported a position in Foghorn Therapeutics in Q1 2024 and held it in 3 quarters.
  • Focus Partners Wealth's Foghorn Therapeutics position peaked at $1.29M in Q2 2024.
  • 93 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q4 2025.

Based on Focus Partners Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.